The origin, in vitro differentiation, and stemness specificity of progenitor cells
Jazyk angličtina Země Singapur Médium print
Typ dokumentu časopisecké články
    PubMed
          
           28685538
           
          
          
      PII:  14
  
    Knihovny.cz E-zdroje
    
  
              
      
- MeSH
- buněčná a tkáňová terapie metody trendy MeSH
- buněčná diferenciace fyziologie MeSH
- folikulární buňky cytologie fyziologie MeSH
- kmenové buňky cytologie fyziologie MeSH
- leukemický inhibiční faktor metabolismus MeSH
- lidé MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- leukemický inhibiční faktor MeSH
- LIF protein, human MeSH Prohlížeč
Since the successful collection of the first progenitor stem cells (SCs), there has been an increased interest in these cells as a model for undiscovered and unlimited potential of differentiation and development. Additionally, it was shown that SC populations display an ability to form pluripotent and/or totipotent cell populations. It was found that human ovarian granulosa cells (GCs) maintain a large capacity for differentiation into several other cell lineages, such as chondrogenic, osteogenic, neurogenic, and adipogenic, particularly during long-term, in vitro culture. In these cases, the specific media supplements that promote various pathways of differentiation, such as leukemia-inhibiting factor (LIF) and/or FSH, are well recognized. However, these are only some examples of the differentiation possibilities of human SCs in vitro and other pathways still require further investigation. Many SC populations, which are directed to differentiate into specific cell types, are also successfully used in several human disease therapies, e.g. leukemia. Moreover, SCs are used for tissue scaffold construction in patients with respiratory and cardiovascular diseases. In this review, the most recent knowledge about the in vitro growth and differentiation capacity of SCs is presented. Furthermore, we discuss the possible worldwide application of SCs in advanced cell and tissue bioengineering. In conclusion, it is suggested that, in the future, SCs will be a basic strategy in human therapy, and their use will open new gates in regenerative and reconstructive medicine in the 21st century.
Department of Anatomy Poznan University of Medical Sciences Poznan Poland
Department of Histology and Embryology Poznan University of Medical Sciences Poznan Poland
Department of Histology and Embryology Wroclaw Medical University Wroclaw Poland
Institute of Veterinary Sciences Poznan University of Life Sciences Poznan Poland
